Building on the continued growth and strong performance of its Life Sciences business, Ecolab is further expanding its global bioprocessing capabilities to support biopharmaceutical manufacturers ...
The bioprocessing market is set to pass $44.19 billion by 2030 from $17.66 billion in 2021, reflecting a compound annual growth rate (CAGR) of 11.0% from 2022 to 2030, according to Next Move Strategy ...
The single-use bioprocessing market offers significant growth opportunities, driven by the demand for enhanced productivity, flexibility, and cost-efficiency. Asia-Pacific is emerging as a key growth ...
Milk exosomes enable scalable drug delivery, advancing safer therapies for inflammatory disease and cancer care.
At INTERPHEX 2026, Bryan Poltilove highlights a novel technology as a promising point-of-use media manufacturing approach ...
Bioprocessing is a broad term that encompasses various techniques and methods used to produce biological products or modify biological materials using living cells or their components. It involves ...
| Bioprocessing is evolving rapidly in a shifting landscape of innovative and complex products, processes and technologies.
insights from industryJustin MorettoLife Science Product Marketing ManagerEndress+Hauser Optical Analysis In this interview, News-Medical talks to Justin Moretto, Life Science Product Manager at ...
Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter. Danaher's revenue for the three months ended Sept. 27 ...
Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results